|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 36/185 | |
| A61K 31/352 | |||
| A61K 31/35 | |||
| A61K 31/05 | |||
| A61K 45/06 | |||
| A61P 25/18 | |||
| A61P 25/22 |
| (11) | Number of the document | 2609928 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13152600.6 |
| Date of filing the European patent application | 2008-12-17 | |
| (97) | Date of publication of the European application | 2013-07-03 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-17 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 0800390 | 2008-01-04 | GB |
| (72) |
Kikuchi, Tetsuro, JP
Maeda, Kenji, JP
Guy, Geoffrey, GB
Robson, Philip, GB
Stott, Colin, GB
|
| (73) |
GW Pharma Limited,
Sovereign House, Histon Cambridge CB24 9BZ,
GB
|
| (54) | Use of cannabinoids in combination with Aripiprazole |
| Use of cannabinoids in combination with Aripiprazole |